Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE) -: Rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease

被引:16
作者
Isaacsohn, JL
Davidson, MH
Hunninghake, D
Singer, R
McLain, R
Black, DM
机构
[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
[2] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA
[3] Chicago Ctr Clin Res, Chicago, IL USA
[4] Univ Minnesota, Dept Med, Minneapolis, MN USA
[5] Univ Minnesota, Dept Pharmacol, Minneapolis, MN USA
关键词
D O I
10.1016/S0002-9149(00)00872-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:250 / 252
页数:3
相关论文
共 13 条
[11]  
Tonkin A, 1998, NEW ENGL J MED, V339, P1349
[12]  
VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131
[13]  
Wood D, 1998, EUR HEART J, V19, P1434